Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Phase IIb studies begin for PT-141 for erectile dysfunction

Aug. 9, 2005

Kyorin and LG Life Sciences sign memorandum of understanding for KRP-197

Aug. 4, 2005

Sevelamer decreases mortality and morbidity of hemodialysis patients

Aug. 3, 2005

New class of intestinal Pi absorption inhibitor

July 28, 2005

Updated labeling for Cialis, Levitra and Viagra

July 20, 2005

Therapeutic benefits of melatonin in hemodialysis patients

July 15, 2005

OxThera created to advance Q-Med's oxalate project

July 14, 2005

Phase IIb study evaluates BXL-628 for benign prostatic hyperplasia

July 13, 2005

Novartis and P&G to copromote Enablex in U.S.

July 11, 2005

Anti-PDGF-D antibody ameliorates mesangioproliferative glomerulonephritis

July 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...